Last 40,000
Change Today -775.00 / -1.90%
Volume 496.0K
As of 10:00 AM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stephen Bradley Saad BCom, CA(SA)

Group Chief Executive Officer and Executive Director, Aspen Pharmacare Holdings Limited
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 1 different industries.

See Board Relationships
50R14,563,000
As of Fiscal Year 2013

Background*

Mr. Stephen Bradley Saad, BCom, CA, serves as the Group Chief Executive Officer of Aspen Pharmacare Holdings Limited since 2000. Mr. Saad served as a Joint Chief Executive of Aspen Pharmacare Holdings Ltd. He has been an Executive Director of Aspen Pharmacare Holdings Limited since January 1999. Mr. Saad is a CA from South Africa Institute of CAs and holds a B.Com through the University of Natal in South Africa.

Corporate Headquarters*

Aspen House
Durban, KwaZulu-Natal 4019

South Africa

Phone: 27 31 580 8600
Fax: 27 31 580 8647

Board Members Memberships*

1999-Present
Group Chief Executive Officer and Executive Director

Education*

Bachelor's Degree
The University of KwaZulu-Natal
Associate's Degree
South African Institute of Chartered Accountants

Other Affiliations*

Annual Compensation*

SalaryR5,609,000
BonusR6,195,000
Total Annual CompensationR11,804,000

Stock Options*

Restricted Stock AwardsR2,173,000
All Other CompensationR586,000

Total Compensation*

Total Annual Cash CompensationR12,390,000
Total Short Term CompensationR11,804,000
Other Long Term CompensationR586,000
Total Calculated CompensationR14,563,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
APN:SJ 40,000.00 -775.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASPEN PHARMACARE HOLDINGS LT, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.